This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Psoriasis  • Dermatologic Procedures  • Phototherapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 1999;135:589-590.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ANY NEW therapy will be received by the medical profession with cautious enthusiasm tempered by healthy skepticism. Only when objective evidence exists that satisfactorily answers the gauntlet of questions regarding indications, efficacy, comparison with existing treatments, method of use, and acute and chronic adverse effects will a new therapy be universally accepted. Where are we in this process with narrowband UV-B TL-01 phototherapy?

Broadband UV-B has long had a major role in the management of moderate-to-severe generalized psoriasis. Traditional electric discharge sources have been replaced by fluorescent phosphor lamps. Yet our knowledge of the optimum method of use and long-term effects is still incomplete. What is the reason for this? When one considers the resources required to register a new drug vs those needed for the development of a new lamp, significant differences exist. The responsibility for investigating a light source is left to the medical profession, but with a . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Narrowband UV-B Phototherapy vs Photochemotherapy in the Treatment of Chronic Plaque-Type Psoriasis: A Paired Comparison Study
Adrian Tanew, Sonja Radakovic-Fijan, Michael Schemper, and Herbert Hönigsmann
Arch Dermatol. 1999;135(5):519-524.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Narrowband (312-nm) UV-B Suppresses Interferon {gamma} and Interleukin (IL) 12 and Increases IL-4 Transcripts: Differential Regulation of Cytokines at the Single-Cell Level
Walters et al.
Arch Dermatol 2003;139:155-161.
ABSTRACT | FULL TEXT  

Recent advances: Dermatology
Foley
BMJ 2000;320:850-853.
FULL TEXT